Total Payments
$38,377
2024 Payments
$38,000
Companies
6
Transactions
16
Medicare Patients
898
Medicare Billing
$45,480
Payment Breakdown by Category
Other$38,000 (99.0%)
Food & Beverage$273.37 (0.7%)
Education$103.22 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $38,000 | 2 | 99.0% |
| Food and Beverage | $273.37 | 11 | 0.7% |
| Education | $103.22 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Galderma Laboratories, L.P. | $38,000 | 2 | $0 (2024) |
| Allergan Inc. | $183.28 | 7 | $0 (2017) |
| W. L. Gore & Associates, Inc. | $88.22 | 2 | $0 (2019) |
| Lilly USA, LLC | $48.56 | 1 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $41.53 | 3 | $0 (2019) |
| Amgen Inc. | $15.00 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $38,000 | 2 | Galderma Laboratories, L.P. ($38,000) |
| 2020 | $15.00 | 1 | Amgen Inc. ($15.00) |
| 2019 | $105.70 | 3 | W. L. Gore & Associates, Inc. ($88.22) |
| 2018 | $72.61 | 3 | Lilly USA, LLC ($48.56) |
| 2017 | $183.28 | 7 | Allergan Inc. ($183.28) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | Galderma Laboratories, L.P. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $19,000.00 | General |
| 09/02/2024 | Galderma Laboratories, L.P. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $19,000.00 | General |
| 12/02/2020 | Amgen Inc. | Otezla (Drug) | Education | In-kind items and services | $15.00 | General |
| Category: Inflammation | ||||||
| 01/22/2019 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 01/18/2019 | W. L. Gore & Associates, Inc. | Vascular Graft (Device) | Education | In-kind items and services | $60.00 | General |
| Category: Devices | ||||||
| 01/18/2019 | W. L. Gore & Associates, Inc. | Vascular Graft (Device) | Education | In-kind items and services | $28.22 | General |
| Category: Devices | ||||||
| 09/24/2018 | Regeneron Healthcare Solutions, Inc. | DUPIXENT DUPILUMAB INJECTION (Biological) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/18/2018 | Regeneron Healthcare Solutions, Inc. | DUPIXENT DUPILUMAB INJECTION (Biological) | Food and Beverage | In-kind items and services | $10.90 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/19/2018 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $48.56 | General |
| Category: Immunology | ||||||
| 11/27/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: NEUROSCIENCE | ||||||
| 04/17/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: NEUROSCIENCE | ||||||
| 03/21/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: NEUROSCIENCE | ||||||
| 03/02/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $82.84 | General |
| Category: NEUROSCIENCE | ||||||
| 01/19/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 148 | 179 | $30,632 | $6,115 |
| 2022 | 7 | 177 | 245 | $41,316 | $9,190 |
| 2021 | 9 | 280 | 361 | $67,122 | $16,422 |
| 2020 | 9 | 293 | 409 | $63,238 | $13,753 |
Total Patients
898
Total Services
1,194
Medicare Billing
$45,480
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 50 | 54 | $10,368 | $2,356 | 22.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 23 | 25 | $7,775 | $1,583 | 20.4% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Facility | 2023 | 21 | 21 | $4,116 | $672.48 | 16.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Facility | 2023 | 14 | 16 | $3,424 | $622.07 | 18.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Facility | 2023 | 15 | 16 | $2,736 | $468.45 | 17.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 13 | 13 | $1,703 | $358.80 | 21.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Facility | 2023 | 12 | 34 | $510.00 | $54.30 | 10.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 39 | 50 | $14,800 | $3,298 | 22.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 54 | 63 | $11,529 | $2,799 | 24.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Facility | 2022 | 24 | 28 | $5,712 | $1,298 | 22.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 11 | 11 | $2,981 | $644.12 | 21.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Facility | 2022 | 16 | 18 | $2,934 | $590.71 | 20.1% |
| 11102 | Biopsy of related skin growth, first growth | Facility | 2022 | 20 | 22 | $2,618 | $487.14 | 18.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Facility | 2022 | 13 | 53 | $742.00 | $73.50 | 9.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 75 | 99 | $27,918 | $7,158 | 25.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 65 | 72 | $12,528 | $3,598 | 28.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 17 | 17 | $7,038 | $1,509 | 21.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Facility | 2021 | 23 | 23 | $5,934 | $1,255 | 21.1% |
| 17110 | Destruction of up to 14 skin growths | Facility | 2021 | 20 | 24 | $4,656 | $1,095 | 23.5% |
| 17000 | Destruction of skin growth | Facility | 2021 | 29 | 30 | $4,650 | $1,024 | 22.0% |
| 11102 | Tangential biopsy of single skin lesion | Facility | 2021 | 20 | 21 | $2,373 | $481.43 | 20.3% |
| 11900 | Injection of up to 7 skin growths | Facility | 2021 | 13 | 13 | $1,157 | $196.43 | 17.0% |
| 17003 | Destruction of 2-14 skin growths | Facility | 2021 | 18 | 62 | $868.00 | $105.63 | 12.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 67 | 80 | $21,402 | $4,172 | 19.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 63 | 74 | $12,580 | $2,604 | 20.7% |
About Dr. Jing Liu, MD
Dr. Jing Liu, MD is a Dermatology healthcare provider based in Bellevue, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/12/2011. The National Provider Identifier (NPI) number assigned to this provider is 1205128022.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jing Liu, MD has received a total of $38,377 in payments from pharmaceutical and medical device companies, with $38,000 received in 2024. These payments were reported across 16 transactions from 6 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($38,000).
As a Medicare-enrolled provider, Liu has provided services to 898 Medicare beneficiaries, totaling 1,194 services with total Medicare billing of $45,480. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Bellevue, WA
- Active Since 05/12/2011
- Last Updated 07/14/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1205128022
Products in Payments
- VRAYLAR (Drug) $100.44
- Vascular Graft (Device) $88.22
- NAMZARIC (Drug) $82.84
- TALTZ (Drug) $48.56
- DUPIXENT DUPILUMAB INJECTION (Biological) $24.05
- DUPIXENT (Biological) $17.48
- Otezla (Drug) $15.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Bellevue
Dr. Clive Liu, Md, MD
Dermatology — Payments: $3.0M
Dermatology $3.0M
Sharon Kelly, Md, MD
Dermatology — Payments: $140,377
Dermatology $140,377
Deetta Gray, M.d., Faad, Frcpc, M.D., FAAD, FRCPC
Dermatology — Payments: $11,798
Dermatology $11,798
Kieu Dang, Pac, PAC
Dermatology — Payments: $11,502
Dermatology $11,502
Diane Chiu, Md, MD
Dermatology — Payments: $8,139
Dermatology $8,139
Dr. Amanda Norton, Dnp, Arnp, DNP, ARNP
Dermatology — Payments: $7,120
Dermatology $7,120